glp 1 compounding update GLP-1 Crackdown Did the FDA Ban Compounded

Millward DJ, Smith K

The announcement triggered swift federal action

Clinical Guidelines and Research Evidence Leading medical organizations, such as KDIGO (Kidney Disease: Improving Global Outcomes) and the American Diabetes Association, endorse GLP-1 receptor agonists for individuals with type 2 diabetes and CKD

Regular monitoring of TSH levels is essential to ensure optimal dosing, with annual review typically recommended once stable

Consequently, DR may be temporarily worsened, and complications may increase from this acute drop in blood glucose, though the long-term effects may prevent further progression of DR

Nat Commun 13(1):92 Laurindo LF, Barbalho SM, Guiguer EL et al (2022) GLP-1a: going beyond traditional use